Trial Profile
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2014
Price :
$35
*
At a glance
- Drugs Pozanicline (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 06 Jun 2014 New trial record